(4-(1-Phenyl-1H-benzo[d]imidazol-2-yl)phenyl)boronic acid

We are (4-(1-Phenyl-1H-benzo[d]imidazol-2-yl)phenyl)boronic acid CAS:952514-79-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(4-(1-Phenyl-1H-benzo[d]imidazol-2-yl)phenyl)boronic acid
CAS.NO:952514-79-3
Synonyms:[4-(1-phenylbenzimidazol-2-yl)phenyl]boronic acid
Molecular Formula:C19H15BN2O2
Molecular Weight:314.14600
 
Physical and Chemical Properties:
Boiling point:150ºC
Flash point:260ºC
 
Specification:
Appearance:White powder
Assay:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:OLED intermediates

(4-(1-Phenyl-1H-benzo[d]imidazol-2-yl)phenyl)boronic acid


Related News: “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.4-cloro-2-fluorobenzaldehído CAS:61072-56-8 Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.N- [4-Ciano-3- (trifluorometil) fenil] -3 – [(4-fluorofenil) tio] -2-hidroxi-2-metilpropionamida CAS:90356-78-8 Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Ácido [4- (4-propilfenil) fenil] borónico CAS:153035-56-4 After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.After several years of R & D and improvement, the production process of commonly used generic drug bulk drugs is relatively mature, and the products of similar companies have high similarities. Therefore, the competitive advantage of bulk drug companies is mainly reflected in cost control. Companies with cost advantages can usually pass Competition to expand production capacity and further gain scale advantages, while having stable, high-quality upstream supply.

Related Products
Product Name
Ethyl 5-bromobenzofuran-2-carboxylate View Details
2-butan-2-yl-3-methoxypyrazine View Details
(S)-Ethyl-N-Boc-pyroglutamate View Details
Ethyl 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylate manufacturer 3,7-Dichloro-8-(dichloromethyl)quinoline manufacturer 5-Fluoro-2-methyl-3-nitrobenzoic acid manufacturer N-(tert-Butoxycarbonyl)sulfamide manufacturer 6-Bromo-2,3-Dihydro-4H-Chromen-4-One manufacturer